4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-009450
Chief Accounting Officer sold 25,000 shares at $25.21 ($630,320)
- Chief Accounting Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2021-03-01 | Option exercise | +25,000 | $8.27 | $206,750 | 25,000 | D: show line 1 in the form |
| Lyon Joseph Douglas Chief Accounting Officer | 2021-03-01 | Sale | −25,000 | $25.21 | $630,320 | 0 | D: show line 2 in the form |
| Open-market sales · 25,000 sh · avg $25.21 · $630,320 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2021-03-01 | Option exercise · Stock Option (Right to Buy) | −25,000 | 4,167 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…